LivaNova PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
LivaNova PLC (LIVN) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $43.27 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-02-25
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $43.27M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $3.58M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $12.01M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $10.07M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2025-12-31 | $43.27M 10-K · filed 2026-02-25 |
| 2024-12-31 | $3.58M 10-K · filed 2025-02-25 |
| 2023-12-31 | $12.01M 10-K · filed 2024-02-29 |
| 2022-12-31 | $10.07M 10-K · filed 2023-02-27 |
| 2021-12-31 | $61.69M 10-K · filed 2022-03-01 |
| 2020-12-31 | $34.83M 10-K · filed 2021-03-01 |
| 2019-12-31 | $22.20M 10-K · filed 2020-03-02 |
| 2018-12-31 | $48.28M 10-K · filed 2019-03-18 |
| 2017-12-31 | $46.80M 10-K · filed 2018-02-28 |
| 2016-12-31 | $2.04M 10-K · filed 2017-03-01 |
| 2015-12-31 | $12.70M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |